Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05692687 · ClinicalTrials.gov registry record
A Post-market Clinical Study to Evaluate the Safety and Performance of the Carbon Fibre Reinforced Polyetheretherketone Metatarso-Phalangeal (MTP) Plate (CoLink® PCR MTP Plate) for the Treatment of Hallux Rigidus
A clinical trial of Hallux Rigidus, sponsored by Invibio.
- Completed
- Registry status
- 18
- Enrollment target
- 3
- Study locations
NCT05692687 is a study of Hallux Rigidus that has completed, run by Invibio. The registered enrollment target is 18 participants. The trial reports 3 study locations across 3 states.
The verdict
NCT05692687, a study of Hallux Rigidus, has completed, sponsored by Invibio.
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
- 3
- Study locations
Study Summary
The clinical study involves the routine treatment of skeletally mature patients who have been diagnosed with hallux rigidus (stiffness of the first metatarso-phalangeal joint in the foot due to arthritis and degeneration of cartilage). It follows standard practice surgery to treat this condition. This type of degenerative arthritis affects the joint of the big toe (hallux) which is attached to the foot. Taking part in this research will involve collecting data of the surgery to remove damaged cartilage and fix the two bones together with screws and a plate (called the CoLink® PCR MTP Plate).
Conditions Studied
Study Locations (3)
Florida
- South Florida Foot and Ankle Center - Lake Worth
Kansas
- University of Kansas Medical Centre - Kansas City
Mississippi
- Mississippi Sports Medicine and Orthopedic Center, - Jackson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2023-03-15 |
| Est. Completion | 2025-08-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05692687
The ClinicalTrials.gov registry entry for NCT05692687 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Invibio, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hallux Rigidus appearing as the primary indexed condition, and to 0 interventions.
NCT05692687 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Florida, Kansas, Mississippi.
Frequently Asked Questions
What is clinical trial NCT05692687 about?
NCT05692687 is a clinical study titled "A Post-market Clinical Study to Evaluate the Safety and Performance of the Carbon Fibre Reinforced Polyetheretherketone Metatarso-Phalangeal (MTP) Plate (CoLink® PCR MTP Plate) for the Treatment of Hallux Rigidus". The clinical study involves the routine treatment of skeletally mature patients who have been diagnosed with hallux rigidus (stiffness of the first metatarso-phalangeal joint in the foot due to arthritis and degeneration of cartilage). It follows standard practice surgery to treat this condition. T...
What is the current status of trial NCT05692687?
This trial is currently completed. The enrollment target is 18 participants. The study started on 2023-03-15. Estimated completion is 2025-08-12.
What conditions does trial NCT05692687 study?
This clinical trial studies the following conditions: Hallux Rigidus.
Who is sponsoring clinical trial NCT05692687?
This trial is sponsored by Invibio, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05692687 being conducted?
This trial has 3 study locations across Florida, Kansas, Mississippi. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hallux Rigidus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.